Are We Ready for Cell Therapy to Treat Stroke?
Clinical trials of cell therapies that target stroke started at the beginning of this century and they have experienced a significant boost in recent years as a result of promising data from basic research studies. The increase in the information available has paved the way to carry out more innovat...
Main Authors: | Fernando José Rascón-Ramírez, Noelia Esteban-García, Juan Antonio Barcia, Albert Trondin, Cristina Nombela, Leyre Sánchez-Sánchez-Rojas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.621645/full |
Similar Items
-
Neurorestoration Approach by Biomaterials in Ischemic Stroke
by: Noelia Esteban-Garcia, et al.
Published: (2020-05-01) -
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by: Aubin Pitiot, et al.
Published: (2022-08-01) -
State of the Art and Future of Stem Cell Therapy in Ischemic Stroke: Why Don’t We Focus on Their Administration?
by: Andrea Valeri, et al.
Published: (2023-01-01) -
Unveiling the Hidden Therapeutic Potential of Carnosine, a Molecule with a Multimodal Mechanism of Action: A Position Paper
by: Giuseppe Caruso
Published: (2022-05-01) -
Directional DBS of the Fornix in Alzheimer’s Disease Achieves Long-Term Benefits: A Case Report
by: Juan A. Barcia, et al.
Published: (2022-04-01)